Login

Antony Mattessich, President & CEO, Ocular Therapeutix 00:00:00

Share On Facebook Share On Twitter

Ocular Therapeutix

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Eurotech's High Performance Edge Computers: Bridging Data Centers to the Field for Real-Time AI Analytics |Paul Chawla, CEO of Eurotech
00:10:00
Anastasia Amoroso from iCapital joins 'Closing Bell' to discuss identifying market upside in specific stocks and shares her market outlook.
00:10:00
Disney's Success: Streaming Growth and Theme Park Revival
00:10:00
you hear people talking about venture capital all the time|Ashley Aydin,Principal,Vamos Ventures
00:10:00
Puuilo Faces Economic Headwinds: CEO Juha Saarela Explains Stable Customer Numbers and Stronger Sales Margins | Juha Saarela, CEO of Puuil OYj.
00:10:00
AVZ Minerals Highlights World's Largest Lithium Project in Congo at One-to-One Mining Conference
00:10:00
Judge Silberman on Second Amendment Originalism|Laurence Silberman
00:10:00
Sean of Davis Wealth Management: Avoiding Financial Pitfalls in Retirement
00:10:00
MSCI is a leading provider of critical decision support tools|Henry A. Fernandez,Chairman,Real Capital Analytics
00:10:00
Millennium is a global alternative investment management firm, founded in 1989, managing over $57 billion in assets.
00:10:00
CENTRAL PATTANA expands its services with digital technology, aiming to be the perfect Future of Retail|CEO,Central Pattana PCL
00:10:00
Maximizing Your Career as Your Most Valuable Asset | Michael Haubrich, CFP, from Financial Service Group Inc

© 2026 Nehu